germac

germac Updated 

Navidea has been around a long time, it started around $20 but has been under a dollar for a few years. They made a big sale mid-2017 which more or less wiped out their debts and their conference call last November gave the impression that their latest drug is a game changer for them. After last week's 4th quarter results and conference call the price nudged up...

germac

I bought in at 3.35 because of the breakout from the rectangular consolidation area, the general uptrend and a small increase in volume. I think that the best time to enter is supposed to be when the breakout closes 3% above the rectangle's top on heavier volume, and I didn't take the chance at the first pennant either - so I may be way too late but hopefully my...

germac

MYnd's share price has fallen steadily for years, but over the last two years daily volume has risen from hundreds of shares traded daily to hundreds of thousands, and on some recent days several million shares. So clearly interest IS building. In 2018 the price has finally poked up above the 200 day moving average a few times; a double bottom has formed and the...

germac

RNN has been falling since 2017. It looks more or less like an inverted head and shoulders where they've hit bottom now. I bought in at 1.81 because the price had closed there, nearly twelve percent above the neckline at 1.61; volume was twice the average. Maybe it didn't really have the look of a good h & s, I may have engaged in wishful thinking... but it's...

germac

PMD is making money and paying 18¢ dividend per quarter. Yesterday they announced that the 2nd quarter revenues were their largest ever and they anticipate more growth... read the report online. You can see from the chart that most of the movement in the price this year has been stuck in an extended rectangle ranging from about 19.25 to 22 dollars; today's rise...

germac

Actinium reached its lowest price in at least five years (maybe lowest ever!) a few months ago and has been moving up since June. The price action over the last week looks like a pennant so maybe there's an opportunity here to make something on another small rise... however note the recent divergence between the price and the RSI peaks, a signal that is...

germac Updated 

Smokey the Bear used to sniff out a fire before it started, remember way back then? CLNE could be one to tickle your nose. You can see it's had a nice run up and now it seems to be biding its time in a pennant formation. The company is making money and with oil's price rise CLNE's natural gas may be a very good alternative to diesel in the near term. There's...

germac Updated 

You certainly should keep an eye on this when trading resumes Monday, the pattern is an indicator for a good move up. Although the breakout looks very good the volume hasn't increased at all which is a concern of course. But it looks good enough that although I'm not an accountant I checked out the 10-K; I think the company is in the black and they have...

germac

You can see from the weekly chart that Northern Oil & Gas had been falling steadily since 2011 but it is possible that in the last few months the trend has reversed with a wide curve now moving up off the bottom. I think the idea of a change of direction may be supported by the large increase in volume - on average the stock is being traded about three times more...

germac

If you were in 6 weeks ago you've made about 3.5 times your investment!! There's so much talk about July's cannabis legalization vote in Canada, you'd have thought that the whole sector would be, well, buzzing, especially the growers/retailers, but this is the only stock out of the 30 I've looked at that's climbing steadily in response. CV Sciences Inc "is...

germac

The two week (15-minute) trendline for XRP is still unbroken! When the previous up trendline was broken on May 6th with the price at $0.88 a short sale was a good bet and if it turned against you the price action was slow enough to get out with only a small loss. The price this morning is $0.68 so you'd be ahead now by 22%. That might not sound like a huge...

germac Updated 

Bellatrix Explorations (BXE) has been watching its share price sinking for years but oil is in recovery now, so maybe this inverse Head & Shoulders is the reversal signal we'd all like to see. The pattern isn't quite textbook picture perfect but it looks close. The breakout happened, and the price has fallen almost all the way back to the neckline, so if we're...

germac Updated 

It looks like CMRE has broken out of the channel, but the breakout isn't exactly convincing... too risky for the moment? What would you want to see/know/hear before risking cash on this one?

germac Updated 

NL has been trending up for two years, although with some serious pullbacks along the way. The last drop was pretty steep, but is it going to jump right back?

germac Updated 

The company seems enthused about their drug trial results and it appears that the market believes them...

germac Updated 

I've marked what I think are a flag and pennant showing a gain of about 38% since January. The press release on Feb 13th about the first quarter 2018 results had this: '...Shahram Askarpour, President of IS&S, added, “I am pleased with the progress we have achieved in establishing a strong market presence solely on the foundation of products we have internally...

germac

Let's Hope. I think Bellatrix Exploration's price action over the last month has developed the look of an upside-down H&S reversal, there was a decent rise in volume on the breakout through the neckline, then a bit of a pullback, and now... well, like I said, let's hope we're moving in the right direction. The price of gasoline at the pump has been moving up...

germac Updated 

Not much to hang your hopes on here, it looks like a double top with the second top being a head and shoulders. The divergence between RSI and price at the two tops is tenuous, but I wish it wasn't even possible to consider it. As far as the financial statement is concerned, it says the IPO was in 2015 and I guess it's standard procedure for biotechs to lose...